SCHEMBL4986940

SCHEMBL4986940

Cc1nc2cc(C(=O)Nc3ccc(C(C)C)cc3)ccc2s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.62
RAB9A P51151 10/20 0.61
NPC1 O15118 8/20 0.61
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
HDAC6 Q9UBN7 2/20 0.58
HDAC3 O15379 1/20 0.58
HDAC1 Q13547 1/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
SMN1; SMN2 Q16637 4/20 0.57
LMNA P02545 1/20 0.55
HTT P42858 2/20 0.53
CASP3 P42574 2/20 0.53
SENP7 Q9BQF6 2/20 0.53
MAPT P10636 3/20 0.53
POLB P06746 2/20 0.53
SENP8 Q96LD8 1/20 0.50
SENP6 Q9GZR1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19860116 0.93 TRPV1 (0.72) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL4984310 0.85 TRPV1 (0.65) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL6308329 0.85 RAB9A (0.55) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL5934320 0.84 TRPV1 (0.58) TRPV1RAB9ANPC1HDAC6HDAC3
SCHEMBL4988297 0.83 TRPV1 (0.88) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL4987540 0.82 TRPV1 (0.71) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL5781167 0.80 TRPV1 (0.72) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL5783405 0.80 TRPV1 (0.76) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL14985573 0.80 TRPV1 (0.79) TRPV1RAB9ANPC1MEN1KMT2A
SCHEMBL25754145 0.79 RAB9A (0.66) TRPV1RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108676-A1 Benzothiazolecarboxamides NEW BENZOTHIAZOLECARBOXAMIDES (SE) 2008-05-08 US claimed
EP-1833809-A1 NEW BENZOTHIAZOLECARBOXAMIDES AstraZeneca AB (SE) 2007-09-19 EP claimed
WO-2006068592-A1 NEW BENZOTHIAZOLECARBOXAMIDES ASTRAZENECA AB (SE) 2006-06-29 WO claimed
US-20080108676-A1 Benzothiazolecarboxamides NEW BENZOTHIAZOLECARBOXAMIDES (SE) 2008-05-08 US disclosed
EP-1833809-A1 NEW BENZOTHIAZOLECARBOXAMIDES AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006068592-A1 NEW BENZOTHIAZOLECARBOXAMIDES ASTRAZENECA AB (SE) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108676-A1 Benzothiazolecarboxamides QDPR, NDUFB5, NDUFB6 TRPV1 356/4885RAB9A 3886/4885NPC1 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.